Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)
Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)
Fineberg, Naomi A.
157dcac1-9fb2-4197-81f3-0167e1224f05
Hollander, Eric
9c199e18-f117-4e49-ab07-8eb26b6eac0c
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Drummond, Lynne M.
97e7b9e2-2aad-4728-a56d-1cb9fc93f71b
Pellegrini, Luca
4ffc642e-8854-43de-ac90-8028f2674692
Laws, Keith R.
031e4f58-3b61-4080-b461-82b16f75bead
Wellsted, David
df3e8467-3fb3-4857-a05b-077bfd239a1e
Reid, Jemma
37491df5-a793-4e45-9769-46d20ea1f50d
Nezgovorova, Vera
31e8c2c6-5aa3-47b6-893e-bc0fc82943b2
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
July 2022
Fineberg, Naomi A.
157dcac1-9fb2-4197-81f3-0167e1224f05
Hollander, Eric
9c199e18-f117-4e49-ab07-8eb26b6eac0c
Grant, Jon E.
07372bd5-8a0d-42b4-b41b-e376c652acf3
Chamberlain, Samuel R.
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Drummond, Lynne M.
97e7b9e2-2aad-4728-a56d-1cb9fc93f71b
Pellegrini, Luca
4ffc642e-8854-43de-ac90-8028f2674692
Laws, Keith R.
031e4f58-3b61-4080-b461-82b16f75bead
Wellsted, David
df3e8467-3fb3-4857-a05b-077bfd239a1e
Reid, Jemma
37491df5-a793-4e45-9769-46d20ea1f50d
Nezgovorova, Vera
31e8c2c6-5aa3-47b6-893e-bc0fc82943b2
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Fineberg, Naomi A., Hollander, Eric, Grant, Jon E., Chamberlain, Samuel R., Drummond, Lynne M., Pellegrini, Luca, Laws, Keith R., Wellsted, David, Reid, Jemma, Nezgovorova, Vera and Baldwin, David S.
(2022)
Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1).
Comprehensive Psychiatry, 116, [152323].
(doi:10.1016/j.comppsych.2022.152323).
This record has no associated files available for download.
More information
e-pub ahead of print date: 28 April 2022
Published date: July 2022
Identifiers
Local EPrints ID: 507724
URI: http://eprints.soton.ac.uk/id/eprint/507724
ISSN: 0010-440X
PURE UUID: 0b5a8574-4fd7-4f0d-b558-a67a283ee9d4
Catalogue record
Date deposited: 19 Dec 2025 18:14
Last modified: 20 Dec 2025 03:25
Export record
Altmetrics
Contributors
Author:
Naomi A. Fineberg
Author:
Eric Hollander
Author:
Jon E. Grant
Author:
Samuel R. Chamberlain
Author:
Lynne M. Drummond
Author:
Luca Pellegrini
Author:
Keith R. Laws
Author:
David Wellsted
Author:
Jemma Reid
Author:
Vera Nezgovorova
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics